Analyst Reco. Biogen Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:07:27 2024-06-10 pm EDT			5-day change	1st Jan Change
226.5 ^USD	+0.49%		-1.28%	-12.33%

01:00pm	US FDA advisers to review Eli Lilly Alzheimer's drug	RE
09:44am	Biogen, Eisai Say Alzheimer's Maintenance Treatment Application Accepted by US FDA	MT

Wedbush Adjusts Price Target on Biogen to $215 From $219	Jun. 06	MT
Wedbush Raises Biogen Price Target to $219 From $215, Maintains Neutral Rating	May. 22	MT
Argus Raises Biogen's Price Target to $250 From $240	May. 15	MT
Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating	May. 08	MT
HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating	May. 03	MT
Guggenheim Adjusts Price Target on Biogen to $255 From $275	Apr. 26	MT
Goldman Sachs Adjusts Biogen Price Target to $340 From $393	Apr. 25	MT
Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305	Apr. 25	MT
Barclays Adjusts Price Target on Biogen to $200 From $215	Apr. 25	MT
HC Wainwright Adjusts Biogen's Price Target to $300 From $325	Apr. 25	MT
Wedbush Adjusts Price Target on Biogen to $215 From $213	Apr. 25	MT
Morgan Stanley Cuts Biogen's Price Target to $331 From $339	Apr. 24	MT
Piper Sandler Raises Biogen's Price Target to $335 From $325	Apr. 24	MT
RBC Lowers Biogen's Price Target to $317 From $326	Apr. 24	MT
Needham Adjusts Price Target on Biogen to $294 From $300	Apr. 19	MT
BMO Capital Adjusts Price Target on Biogen to $260 From $285, Outperform Rating Kept	Apr. 19	MT
Oppenheimer Adjusts Biogen Price Target to $270 From $290	Apr. 19	MT
UBS Adjusts Biogen's Price Target to $214 From $250, Maintains Neutral Rating	Apr. 17	MT
Wedbush Cuts Biogen's Price Target to $213 From $245	Apr. 17	MT
Argus Adjusts Biogen's Price Target to $240 From $315	Apr. 15	MT

No results for this search